Immatics N.V. 4

Perceptive Life Sciences Master Fund Ltd., through Perceptive Advisors LLC and Joseph Edelman, bought 863,060 Immatics N.V. ordinary shares at about $8.69 each on August 26, 2026.

On August 26, 2026, Perceptive Life Sciences Master Fund Ltd., advised by Perceptive Advisors LLC and managed by Joseph Edelman, purchased 863,060 ordinary shares of Immatics N.V. at an average price of $8.69 per share, for an aggregate purchase of approximately $7.51 million. Following this transaction, the Master Fund’s indirect beneficial holdings in Immatics increased to 11,246,516 ordinary shares. Perceptive Advisors LLC and Mr. Edelman report these holdings due to their investment manager and control roles but expressly disclaim beneficial ownership except to the extent of their indirect pecuniary interest, indicating this is a fund-level investment rather than a direct personal purchase by Mr. Edelman.

Filing Facts

CIK

1809196

Ticker

IMTX

Form

4

Source Type

fda

Accession

0001193125-26-371237

Alert Tier

8